SCHEMBL3756453

SCHEMBL3756453

O=C(O)N(CCCF)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868996 0.79 TSHR (0.35)
SCHEMBL3753416 0.74 CAMK2A (0.41)
SCHEMBL537217 0.74 LMNA (0.48)
SCHEMBL9051005 0.72 TSHR (0.33)
SCHEMBL455742 0.72 CA12 (0.46)
SCHEMBL31662731 0.72 TDP1 (0.35)
SCHEMBL6756458 0.72 TDP1 (0.35)
SCHEMBL19817170 0.70 CA12 (0.31)
SCHEMBL19833104 0.70 ODC1 (0.32)
SCHEMBL19615405 0.70 TDP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias ASTRAZENECA AB (SE) 2010-11-25 US disclosed
EP-2049484-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS AstraZeneca AB (SE) 2009-04-22 EP disclosed
WO-2008008022-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS ASTRAZENECA AB (SE) 2008-01-17 WO disclosed
US-20080015237-A1 NEW COMPOUNDS I/418 ASTRAZENECA AB (SE) 2008-01-17 US disclosed